This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Guilherme, L. Articles by Kalil, J. Search for Related Content PubMed PubMed Citation Articles by Guilherme, L. Articles by Kalil, J.

Circulation, Vol 83, 1995-1998, Copyright © 1991 by American Heart Association

ARTICLES

Association of human leukocyte class II antigens with rheumatic fever or rheumatic heart disease in a Brazilian population

L Guilherme, W Weidebach, MH Kiss, R Snitcowsky and J Kalil
Heart Institute, Hospital of Clinics, Faculty of Medicine, University of Sao Paulo, Brazil.

BACKGROUND. The incidence of rheumatic heart disease is great in Brazil. We analyzed the distribution of human leukocyte (HLA) antigens in a Brazilian population sample with rheumatic fever or rheumatic heart disease, with the aim of better understanding the mechanisms involved. METHODS AND RESULTS. HLA class I (A, B, and C) and class II (DR and DQ) antigen distribution was studied in 40 patients with diagnosis of rheumatic fever or rheumatic heart disease and compared with a control group of 617 healthy individuals for class I typing, from which 118 were drawn for class II typing. A strong correlation between rheumatic fever and rheumatic heart disease and HLA-DRw53 (72.9% in the disease group versus 39% in the control group: p = 0.00061, relative risk, 4.2; etiologic fraction, 0.43) was found. We also found an increase in the frequency of HLA-DR7 (57.5% in the disease group versus 26.3% in control group: p = 0.00715; relative risk, 3.8; etiologic fraction, 0.56). HLA class I and HLA-DQ typing did not point to any association with these diseases. CONCLUSIONS. HLA-DR7 and HLA-DRw53 are markers for susceptibility to rheumatic fever and rheumatic heart disease in Brazil. These results could be explained by genetic differences resulting from racial or geographical diversity.

This article has been cited by other articles:

				L. Guilherme, S. E. Oshiro, K. C. Fae, E. Cunha-Neto, G. Renesto, A. C. Goldberg, A. C. Tanaka, P. M. A Pomerantzeff, M. H. Kiss, C. Silva, et al. T-Cell Reactivity against Streptococcal Antigens in the Periphery Mirrors Reactivity of Heart-Infiltrating T Lymphocytes in Rheumatic Heart Disease Patients Infect. Immun., September 1, 2001; 69(9): 5345 - 5351. [Abstract] [Full Text] [PDF]

				L. Guilherme, N. Dulphy, C. Douay, V. Coelho, E. Cunha-Neto, S. E. Oshiro, R. V Assis, A. C. Tanaka, P. M. Alberto Pomerantzeff, D. Charron, et al. Molecular evidence for antigen-driven immune responses in cardiac lesions of rheumatic heart disease patients Int. Immunol., July 1, 2000; 12(7): 1063 - 1074. [Abstract] [Full Text] [PDF]

				Y. Guedez, A. Kotby, M. El-Demellawy, A. Galal, G. Thomson, S. Zaher, S. Kassem, and M. Kotb HLA Class II Associations With Rheumatic Heart Disease Are More Evident and Consistent Among Clinically Homogeneous Patients Circulation, June 1, 1999; 99(21): 2784 - 2790. [Abstract] [Full Text] [PDF]

				L. Guilherme, E. Cunha-Neto, V. Coelho, R. Snitcowsky, P. M. A. Pomerantzeff, R. V. Assis, F. Pedra, J. Neumann, A. Goldberg, M. E. Patarroyo, et al. Human Heart–Infiltrating T-Cell Clones From Rheumatic Heart Disease Patients Recognize Both Streptococcal and Cardiac Proteins Circulation, August 1, 1995; 92(3): 415 - 420. [Abstract] [Full Text]